| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 26.209 | 25.047 | 29.818 | 27.005 | 27.105 | 32.737 | 23.458 | 28.569 | 44.367 | 45.948 |
| Total Income - EUR | 26.209 | 25.047 | 29.818 | 27.008 | 27.105 | 32.737 | 23.458 | 28.569 | 44.367 | 45.948 |
| Total Expenses - EUR | 21.106 | 18.854 | 18.909 | 16.965 | 15.297 | 16.957 | 15.127 | 15.903 | 22.179 | 20.722 |
| Gross Profit/Loss - EUR | 5.103 | 6.193 | 10.909 | 10.043 | 11.807 | 15.780 | 8.330 | 12.666 | 22.188 | 25.227 |
| Net Profit/Loss - EUR | 4.317 | 5.692 | 10.610 | 9.772 | 11.536 | 15.452 | 8.095 | 12.380 | 21.744 | 24.835 |
| Employees | 1 | 0 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 1 |
Check the financial reports for the company - Garpromed Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 0 | 0 | 24 | 19 | 0 | 0 | 18 | 0 | 18 | 18 |
| Current Assets | 10.031 | 6.980 | 17.618 | 11.169 | 13.065 | 16.975 | 9.579 | 12.973 | 22.794 | 31.452 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 8.190 | 5.757 | 16.386 | 9.962 | 11.044 | 14.103 | 7.431 | 9.735 | 17.330 | 25.474 |
| Cash | 1.841 | 1.223 | 1.232 | 1.208 | 2.022 | 2.872 | 2.148 | 3.238 | 5.464 | 5.979 |
| Shareholders Funds | 4.371 | 5.746 | 10.662 | 9.824 | 11.587 | 15.502 | 8.144 | 12.429 | 21.792 | 30.423 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 5.660 | 1.234 | 6.979 | 1.365 | 1.478 | 1.474 | 1.454 | 544 | 1.020 | 1.048 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8559 - 8559" | |||||||||
| CAEN Financial Year |
8559
|
|||||||||
Comments - Garpromed Srl